Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FWT23
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,159
Award facts
- Contract value 100% obligated
- $11,159.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,159.12 delivery order to AmerisourceBergen Drug Corp for the supply of Xolair 300 mg/2 mL autoinjectors on August 5, 2025, with completion targeted for August 26, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Xolair (omalizumab) is a monoclonal antibody used to treat moderate-to-severe asthma and chronic urticaria, representing a specialized pharmaceutical product critical to military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of medications and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and federal medical procurement vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency and serves customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FWT23?
SPE2DB25FWT23 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FWT23 worth?
The government has obligated $11,159 on SPE2DB25FWT23.
Is contract SPE2DB25FWT23 an order under another contract?
Yes. SPE2DB25FWT23 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWT23 competed?
The extent of competition for SPE2DB25FWT23 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award